{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Polepally, Jadcherla",
      "state": "N/A",
      "country": "India",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "86749",
      "recalling_firm": "Shilpa Medicare Limited",
      "address_1": "S-20 To S-26,  Pharm. Formulation Sez",
      "address_2": "Tsiic, Green Industrial Park",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the U.S.",
      "recall_number": "D-0121-2021",
      "product_description": "Busulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only, Must be diluted before use, Single Dose Vial, Sterile, Cytotoxic Agent, Rx Only, 10 mL vial, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, Vial NDC 72485-210-01, Carton NDC 72485-210-08.",
      "product_quantity": "2,064 vials",
      "reason_for_recall": "CGMP Deviations",
      "recall_initiation_date": "20201208",
      "center_classification_date": "20201209",
      "termination_date": "20220311",
      "report_date": "20201216",
      "code_info": "Lot #: 7S10008B, Exp. 12/31/2020"
    }
  ]
}